94 related articles for article (PubMed ID: 9095530)
21. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
22. Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation.
Li G; Tang L; Hou C; Wang Z; Gao Y; Dou S; Mo R; Hao Y; Gao Z; Li Y; Dong J; Zhang J; Shen B; Wang R; Han G
Front Immunol; 2021; 12():667478. PubMed ID: 34025669
[TBL] [Abstract][Full Text] [Related]
23. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
24. Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon.
Ciavarra RP; Taylor L; Greene AR; Yousefieh N; Horeth D; van Rooijen N; Steel C; Gregory B; Birkenbach M; Sekellick M
Virology; 2005 Nov; 342(2):177-89. PubMed ID: 16143360
[TBL] [Abstract][Full Text] [Related]
25. Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-alpha.
Orzechowska B; Antoszków Z; Siemieniec I; Lorenc M; Jatczak B; Błach-Olszewska Z
Arch Immunol Ther Exp (Warsz); 2007; 55(2):111-7. PubMed ID: 17417691
[TBL] [Abstract][Full Text] [Related]
26. The role of the proteasome-ubiquitin pathway in regulation of the IFN-gamma mediated anti-VSV response in neurons.
Yang J; Tugal D; Reiss CS
J Neuroimmunol; 2006 Dec; 181(1-2):34-45. PubMed ID: 16959328
[TBL] [Abstract][Full Text] [Related]
27. Immunology. Eating in to avoid infection.
Reis e Sousa C
Science; 2007 Mar; 315(5817):1376-7. PubMed ID: 17347432
[No Abstract] [Full Text] [Related]
28. Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.
Ireland DD; Reiss CS
Viral Immunol; 2006; 19(3):536-45. PubMed ID: 16987071
[TBL] [Abstract][Full Text] [Related]
29. MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus.
Lang KS; Navarini AA; Recher M; Lang PA; Heikenwalder M; Stecher B; Bergthaler A; Odermatt B; Akira S; Honda K; Hengartner H; Zinkernagel RM
Eur J Immunol; 2007 Sep; 37(9):2434-40. PubMed ID: 17668900
[TBL] [Abstract][Full Text] [Related]
30. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
31. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha.
Publicover J; Ramsburg E; Robek M; Rose JK
J Virol; 2006 Jul; 80(14):7028-36. PubMed ID: 16809308
[TBL] [Abstract][Full Text] [Related]
32. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells.
Waibler Z; Detje CN; Bell JC; Kalinke U
Immunobiology; 2007; 212(9-10):887-94. PubMed ID: 18086387
[TBL] [Abstract][Full Text] [Related]
33. NSAID treatment suppresses VSV propagation in mouse CNS.
Chen N; Warner JL; Reiss CS
Virology; 2000 Oct; 276(1):44-51. PubMed ID: 11021993
[TBL] [Abstract][Full Text] [Related]
34. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system.
Plakhov IV; Arlund EE; Aoki C; Reiss CS
Virology; 1995 May; 209(1):257-62. PubMed ID: 7747478
[TBL] [Abstract][Full Text] [Related]
35. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
Huneycutt BS; Bi Z; Aoki CJ; Reiss CS
J Virol; 1993 Nov; 67(11):6698-706. PubMed ID: 8105106
[TBL] [Abstract][Full Text] [Related]
36. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.
Iannacone M; Moseman EA; Tonti E; Bosurgi L; Junt T; Henrickson SE; Whelan SP; Guidotti LG; von Andrian UH
Nature; 2010 Jun; 465(7301):1079-83. PubMed ID: 20577213
[TBL] [Abstract][Full Text] [Related]
37. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
Akbasak A; Oldfield EH; Saris SC
J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
[TBL] [Abstract][Full Text] [Related]
38. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
Orzechowska B; Antoszków Z; Błach-Olszewska Z
Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
[TBL] [Abstract][Full Text] [Related]
39. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
40. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
